| Literature DB >> 32256098 |
Yuxin Wang1, Meishuo Ouyang2, Xibao Gao1, Shuai Wang3, Chunyang Fu1, Jiayi Zeng1, Xiaodong He1,4.
Abstract
PURPOSE: The purpose of this study was to explore the difference and association between intestinal microbiota and plasma metabolomics between type 2 diabetes mellitus (T2DM) and normal group and to identify potential microbiota biomarkers that contribute the most to the difference in metabolites.Entities:
Keywords: 16S rRNA sequencing; Zucker diabetic fatty rats; intestinal microbiota; plasma metabolomics; type 2 diabetes mellitus
Year: 2020 PMID: 32256098 PMCID: PMC7090210 DOI: 10.2147/DMSO.S240728
Source DB: PubMed Journal: Diabetes Metab Syndr Obes ISSN: 1178-7007 Impact factor: 3.168
Figure 1(A) Relative Abundance. Relative gut microbiota abundance at class (A1) and family (A2) level in fa/fa group and fa/+ group. Sample Name gN.1 to gN.6 belonged to fa/+ group, gP.1 to gP.6 belonged to fa/fa group. (B) Rarefaction curve of each sample with 97% identity. (C) PCA Plot. The abscissa represents the first principal component (PC1). The ordinate represents the second principal component (PC2). The percentage represents the contribution value of PC1 or PC2 to the sample difference.
Figure 2Metastat analysis uses the hypothesis test of species abundance data between groups to obtain the p-value, which was then corrected to obtain the q-value, then filtered species had significant differences according to it. *q < 0.05.
Abbreviations: f, family; g, genus; s, species.
Figure 3LEfSe (LDA Effect Size) can discover and interpret high-dimensional biomarkers, and emphasize statistical significance and biological correlation between groups. (A) Distribution histogram of LDA values shows the species only with LDA Score larger than 4, the length of which represents the impact size of different species (LDA Score). (B) Cladogram represents the taxonomic levels from phylum to species. The diameter of each small circle is proportional to the relative abundance.
Abbreviations: c, class; o, order; f, family; g, genus; s, species.
Figure 4(A) Controls were separated from model rats in metabolite profiles by PCA. (B) The plasma metabolic profile of model group changed with 357 molecular features being significantly changed compared with control group (p < 0.05).
Figure 5Relative Quantification of (A) PC(16:0/16:1(9Z)) (B) PC(18:0/20:3(5Z,8Z,11Z)) (C) PE(16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z) deoxycholic acid (D) that differed significantly between fa/fa group and fa/+ group. *p<0.05; ***p<0.001.
Abbreviations: PC, phosphatidylcholine; PE, phosphatidylethanolamine.
Figure 6Correlation plot showing the correlation between perturbed gut bacteria and altered plasma metabolites.
Abbreviations: p, phylum; c, class; o, order; f, family; g, genus; s, species.
Results of Association Analysis of Differential Metabolites and Biomarkers of Bacterial Flora. The Results in the Table Only Contain the Metabolite with p Value Less Than 0.05 and Rho Was Greater Than 0.8, as Well as Their Associated Flora
| Taxonomy | Flora | Metabolites | Rho | |
|---|---|---|---|---|
| Name | Change | |||
| Class | Erysipelotrichia | Deoxycholic acid | ↓ | 0.8454 |
| Order | Erysipelotrichales | Deoxycholic acid | ↓ | 0.8454 |
| Family | Erysipelotrichaceae | Deoxycholic acid | ↓ | 0.8454 |
| Peptostreptococcaceae | Deoxycholic acid | ↓ | 0.9073 | |
| Genus | Phocea | PE(20:3(8Z,11Z,14Z)/21:0) | ↑ | 0.8062 |
| PE-NMe2 (36:4) | ↑ | 0.8471 | ||
| PE(18:0/18:2(9Z,12Z)) | ↑ | 0.8870 | ||
| PG(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.8346 | ||
| PC(17:0/20:3(8Z,11Z,14Z)) | ↑ | 0.8452 | ||
| Galabiosylceramide (d18:1/18:0) | ↑ | 0.8569 | ||
| DG(18:2n6/0:0/22:6n3) | ↑ | 0.8520 | ||
| PC(15:0/18:1(11Z)) | ↑ | 0.8807 | ||
| PI(18:0/22:4(10Z,13Z,16Z,19Z)) | ↑ | 0.8023 | ||
| PI(18:0/20:3(5Z,8Z,11Z)) | ↑ | 0.8697 | ||
| PS (20:5(5Z,8Z,11Z,14Z,17Z)/22:0) | ↑ | 0.8381 | ||
| PE(34:2) | ↑ | 0.8394 | ||
| PE-NMe2 (34:4) | ↑ | 0.8351 | ||
| 4Z,8Z-Heptadecadiene | ↑ | 0.8415 | ||
| DG(18:2n6/0:0/22:5n6) | ↑ | 0.8575 | ||
| PG(21:0/22:4(7Z,10Z,13Z,16Z)) | ↑ | 0.8359 | ||
| N-Oleoylglycine | ↑ | 0.8796 | ||
| (Z)-13-Octadecenoic acid | ↑ | 0.8582 | ||
| DG(18:0/0:0/18:2n6) | ↑ | 0.8873 | ||
| Pseudoflavonifractor | PE-NMe2 (36:4) | ↑ | 0.8110 | |
| N-Oleoylglycine | ↑ | 0.8043 | ||
| DG(18:0/0:0/18:2n6) | ↑ | 0.8090 | ||
| Romboutsia | Deoxycholic acid | ↑ | 0.9042 | |
| Turicibacter | Deoxycholic acid | ↑ | 0.8935 | |
| Blautia | Monoolein | ↑ | 0.8037 | |
| Phocea | Monoolein | ↑ | 0.8139 | |
| CE (20:4(5Z,8Z,11Z,14Z) | ↓ | 0.8255 | ||
| LysoPC(20:3(5Z,8Z,11Z)) | ↑ | 0.8581 | ||
| PC(14:0/20:4(5Z,8Z,11Z,14Z)) | ↑ | 0.8641 | ||
| PE(16:0/22:6) | ↑ | 0.8584 | ||
| PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.8735 | ||
| PC(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.8670 | ||
| PE-NMe2 (34:1) | ↑ | 0.8147 | ||
| PE(18:0/18:1(9Z)) | ↑ | 0.8108 | ||
| PE-NMe2 (34:2) | ↑ | 0.8369 | ||
| PC(18:0/20:3(5Z,8Z,11Z)) | ↑ | 0.8654 | ||
| 20-oxo-heneicosanoic acid | ↑ | 0.8995 | ||
| Ala-Gln-Lys | ↓ | 0.8377 | ||
| Zymosteryl oleate | ↓ | 0.8191 | ||
| C25:4 Highly branched isoprenoid B | ↓ | 0.8143 | ||
| PE-NMe2 (36:2) | ↑ | 0.8148 | ||
| SM(d18:1/14:0) | ↑ | 0.8063 | ||
| LysoPC(20:3(5Z,8Z,11Z)) | ↑ | 0.8678 | ||
| Linalyl anthranilate | ↑ | 0.8676 | ||
| Pseudoflavonifractor | PE(16:0/22:6) | ↑ | 0.8056 | |
| PE (18:0/18:1(9Z)) | ↑ | 0.8185 | ||
| 20-oxo-heneicosanoic acid | ↑ | 0.8279 | ||
| Ala-Gln-Lys | ↓ | 0.8089 | ||
| 1,6Z,9Z-Heptadecatriene | ↓ | 0.8020 | ||
| Species | PE(20:3(8Z,11Z,14Z)/21:0) | ↑ | 0.8012 | |
| PG(21:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.8585 | ||
| DG(18:2n6/0:0/22:6n3) | ↑ | 0.8075 | ||
| PC(15:0/18:1(11Z)) | ↑ | 0.8071 | ||
| PI(18:0/22:4(10Z,13Z,16Z,19Z)) | ↑ | 0.8006 | ||
| PI(18:0/20:3(5Z,8Z,11Z)) | ↑ | 0.8017 | ||
| 4Z,8Z-Heptadecadiene | ↑ | 0.8158 | ||
| PA(20:3(8Z,11Z,14Z)/19:1(9Z)) | ↑ | 0.8070 | ||
| DG(18:2n6/0:0/22:5n6) | ↑ | 0.8191 | ||
| N-Oleoylglycine | ↑ | 0.8204 | ||
| (Z)-13-Octadecenoic acid | ↑ | 0.8053 | ||
| DG(18:0/0:0/18:2n6) | ↑ | 0.8101 | ||
| Monoolein | ↑ | 0.8676 | ||
| LysoPC(20:3(5Z,8Z,11Z)) | ↑ | 0.8732 | ||
| PC(14:0/20:4(5Z,8Z,11Z,14Z)) | ↑ | 0.8303 | ||
| PI(18:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.8182 | ||
| PC(20:3(5Z,8Z,11Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) | ↑ | 0.9610 | ||
| 20-oxo-heneicosanoic acid | ↑ | 0.8198 | ||
| PE-NMe2 (36:2) | ↑ | 0.8078 | ||
| LysoPC(20:3(5Z,8Z,11Z)) | ↑ | 0.8556 | ||
| Linalyl anthranilate | ↑ | 0.8550 | ||
Abbreviations: PE, phosphatidylethanolamines; PG, phosphatidylglycerols; PC, phosphatidylcholines; DG, diacylglycerols; PI, phosphatidylinositols; PS, phosphatidylserines; PE-NMe, phosphatidyl-N-dimethylethanolamine; CE, cholesteryl ester; SM, sphingomyelin.